33V-12125-83081
4 vaccinations
0 coded responses
5 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 109 / NY
- Registered
- 2022-10-27
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-22
Dose 1 — Pfizer-BioNTech
-
2021-05-13
Dose 2 — Pfizer-BioNTech
-
2021-12-03
Dose 3 — Pfizer-BioNTech
-
2022-10-27
Registered in v-safe
-
2022-10-27
Dose 4 — Pfizer-BioNTech
-
2022-10-27
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-28
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-10-30
- 2022-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-22 | Pfizer-BioNTech | No |
| 2 | 2021-05-13 | Pfizer-BioNTech | No |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
| 4 | 2022-10-27 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.